Girman CJ, Dekker JM, Rhodes T, Nijpels G, Stehouwer CDA, Bouter LM, et al. An exploratory analysis of criteria for the metabolic syndrome and its prediction of long-term cardiovascular outcomes: the Hoorn study. Am J Epidemiol. 2005;162(5):438–47.
Article
PubMed
Google Scholar
Kivimäki M, Kuosma E, Ferrie JE, Luukkonen R, Nyberg ST, Alfredsson L, et al. Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and Europe. Lancet Public Health. 2017;2(6):e277-85.
Article
PubMed
PubMed Central
Google Scholar
Kassi E, Pervanidou P, Kaltsas G, Chrousos G. Metabolic syndrome: definitions and controversies. BMC Med. 2011;5:48.
Article
Google Scholar
Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24(4):683–9.
Article
CAS
PubMed
Google Scholar
Malik S, Wong ND, Franklin SS, Kamath TV, L’Italien GJ, Pio JR, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110(10):1245–50.
Article
PubMed
Google Scholar
Bhugra D. The global prevalence of schizophrenia. PLoS Med. 2005;9(5):e151 quiz e175.
Article
Google Scholar
Miller BJ, Paschall CB, Svendsen DP. Mortality and medical comorbidity among patients with serious mental illness. Psychiatr Serv Wash DC. 2006;57(10):1482–7.
Article
Google Scholar
Wilson PWF, D’Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005;112(20):3066–72.
Article
CAS
PubMed
Google Scholar
Mitchell AJ, Vancampfort D, De Herdt A, Yu W, De Hert M. Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients. Schizophr Bull. 2013;39(2):295–305.
Article
PubMed
Google Scholar
Meyer JM. Antipsychotics and metabolics in the post-CATIE era. Curr Top Behav Neurosci. 2010;4:23–42.
Article
PubMed
Google Scholar
Meyer JM, Stahl SM. The metabolic syndrome and schizophrenia. Acta Psychiatr Scand. 2009;119(1):4–14.
Article
CAS
PubMed
Google Scholar
McEvoy JP, Meyer JM, Goff DC, Nasrallah HA, Davis SM, Sullivan L, et al. Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr Res. 2005;80(1):19–32.
Article
PubMed
Google Scholar
Correll CU, Joffe BI, Rosen LM, Sullivan TB, Joffe RT. Cardiovascular and cerebrovascular risk factors and events associated with second-generation antipsychotic compared to antidepressant use in a non-elderly adult sample: results from a claims-based inception cohort study. World Psychiatry Off J World Psychiatr Assoc WPA. 2015;14(1):56–63.
Google Scholar
Manu P, Correll CU, Wampers M, Mitchell AJ, Probst M, Vancampfort D, et al. Markers of inflammation in schizophrenia: association vs. causation. World Psychiatry Off J World Psychiatr Assoc WPA. 2014;13(2):189–92.
Google Scholar
Nousen EK, Franco JG, Sullivan EL. Unraveling the mechanisms responsible for the comorbidity between metabolic syndrome and mental health disorders. Neuroendocrinology. 2013;98(4):254–66.
Article
CAS
PubMed
Google Scholar
Rethorst CD, Bernstein I, Trivedi MH. Inflammation, obesity, and metabolic syndrome in depression: analysis of the 2009–2010 National Health and Nutrition Examination Survey (NHANES). J Clin Psychiatry. 2014;75(12):e1428-32.
Article
PubMed
PubMed Central
Google Scholar
Vancampfort D, Stubbs B, Mitchell AJ, De Hert M, Wampers M, Ward PB, et al. Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. World Psychiatry Off J World Psychiatr Assoc WPA. 2015;14(3):339–47.
Google Scholar
Obel N, Thomsen HF, Kronborg G, Larsen CS, Hildebrandt PR, Sørensen HT, et al. Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study. Clin Infect Dis Off Publ Infect Dis Soc Am. 2007;15(12):1625–31.
Article
Google Scholar
Shah RV, Murthy VL, Abbasi SA, Blankstein R, Kwong RY, Goldfine AB, et al. Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study. JACC Cardiovasc Imaging. 2014;7(12):1221–35.
Article
PubMed
PubMed Central
Google Scholar
Currier JS, Taylor A, Boyd F, Dezii CM, Kawabata H, Burtcel B, et al. Coronary heart disease in HIV-infected individuals. J Acquir Immune Defic Syndr 1999. 2003;33(4):506–12.
Article
Google Scholar
Durand M, Sheehy O, Baril JG, Lelorier J, Tremblay CL. Association between HIV infection, antiretroviral therapy, and risk of acute myocardial infarction: a cohort and nested case-control study using Québec’s public health insurance database. J Acquir Immune Defic Syndr. 2011;57(3):245–53.
Article
PubMed
Google Scholar
Masyuko SJ, Page ST, Kinuthia J, Osoti AO, Polyak SJ, Otieno FC, et al. Metabolic syndrome and 10-year cardiovascular risk among HIV-positive and HIV-negative adults: a cross-sectional study. Medicine (Baltimore). 2020;99(27).
Article
CAS
PubMed
PubMed Central
Google Scholar
Nou E, Lo J, Grinspoon SK. Inflammation, immune activation, and cardiovascular disease in HIV. AIDS Lond Engl. 2016;30(10):1495–509.
Article
CAS
Google Scholar
De Santis JP. HIV infection risk factors among male-to-female transgender persons: a review of the literature. J Assoc Nurses AIDS Care JANAC. 2009;20(5):362–72.
Article
PubMed
Google Scholar
Emul M, Kalelioglu T. Etiology of cardiovascular disease in patients with schizophrenia: current perspectives. Neuropsychiatr Dis Treat. 2015;11:2493–503.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mdodo R, Frazier EL, Dube SR, Mattson CL, Sutton MY, Brooks JT, et al. Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys. Ann Intern Med. 2015;162(3):335–44.
Article
PubMed
Google Scholar
Burns DM. Epidemiology of smoking-induced cardiovascular disease. Prog Cardiovasc Dis. 2003;46(1):11–29.
Article
PubMed
Google Scholar
Shah ASV, Stelzle D, Lee KK, Beck EJ, Alam S, Clifford S, et al. Global burden of atherosclerotic cardiovascular disease in people living with HIV: systematic review and meta-analysis. Circulation. 2018;138(11):1100–12.
Article
PubMed
PubMed Central
Google Scholar
Verhaeghe N, De Maeseneer J, Maes L, Van Heeringen C, Annemans L. Effectiveness and cost-effectiveness of lifestyle interventions on physical activity and eating habits in persons with severe mental disorders: a systematic review. Int J Behav Nutr Phys Act. 2011;11:28.
Article
Google Scholar
Todowede OO, Mianda SZ, Sartorius B. Prevalence of metabolic syndrome among HIV-positive and HIV-negative populations in sub-Saharan Africa-a systematic review and meta-analysis. Syst Rev. 2019;3(1):4.
Article
Google Scholar
Riley L, Guthold R, Cowan M, Savin S, Bhatti L, Armstrong T, et al. The World Health Organization STEPwise approach to noncommunicable disease risk-factor surveillance: methods, challenges, and opportunities. Am J Public Health. 2016;106(1):74–8.
Article
PubMed
PubMed Central
Google Scholar
Opondo PR, Ho-Foster AR, Ayugi J, Hatitchki B, Pumar M, Bilker WB, et al. HIV prevalence among hospitalized patients at the main psychiatric referral Hospital in Botswana. AIDS Behav. 2018;22(5):1503–16.
Article
PubMed
PubMed Central
Google Scholar
Agaba DC, Migisha R, Namayanja R, Katamba G, Lugobe HM, Aheisibwe H, et al. Prevalence and Associated Factors of Metabolic Syndrome among Patients with Severe Mental Illness Attending a Tertiary Hospital in Southwest Uganda. BioMed Res Int. 2019;2019:1096201.
Article
PubMed
PubMed Central
Google Scholar
Teshome T, Kassa DH, Hirigo AT. Prevalence and Associated Factors of Metabolic Syndrome Among Patients with Severe Mental Illness at Hawassa, Southern-Ethiopia. Diabetes Metab Syndr Obes Targets Ther. 2020;13:569–79.
Article
Google Scholar
Saloojee S, Burns JK, Motala AA. Metabolic syndrome in South African patients with severe mental illness: prevalence and associated risk factors. PLoS ONE. 2016;11(2):e0149209.
Article
PubMed
PubMed Central
Google Scholar
Alvarez C, Salazar R, Galindez J, Rangel F, Castaãeda ML, Lopardo G, et al. Metabolic syndrome in HIV-infected patients receiving antiretroviral therapy in Latin America. Braz J Infect Dis Off Publ Braz Soc Infect Dis. 2010;14(3):256–63.
CAS
Google Scholar
Srisurapanont M, Likhitsathian S, Boonyanaruthee V, Charnsilp C, Jarusuraisin N. Metabolic syndrome in Thai schizophrenic patients: a naturalistic one-year follow-up study. BMC Psychiatry. 2007;23:14.
Article
Google Scholar
Teixeira PJR, Rocha FL. The prevalence of metabolic syndrome among psychiatric inpatients in Brazil. Rev Bras Psiquiatr Sao Paulo Braz 1999. 2007;29(4):330–6.
Google Scholar
Gardner-Sood P, Lally J, Smith S, Atakan Z, Ismail K, Greenwood KE, et al. Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial. Psychol Med. 2015;45(12):2619–29.
Article
CAS
PubMed
PubMed Central
Google Scholar
John AP, Koloth R, Dragovic M, Lim SCB. Prevalence of metabolic syndrome among Australians with severe mental illness. Med J Aust. 2009;16(4):176–9.
Article
Google Scholar
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;16(19):2486–97.
Article
Google Scholar
Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–5.
Article
CAS
PubMed
Google Scholar
Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome–a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med J Br Diabet Assoc. 2006;23(5):469–80.
Article
CAS
Google Scholar
Stahl SM, Mignon L, Meyer JM. Which comes first: atypical antipsychotic treatment or cardiometabolic risk? Acta Psychiatr Scand. 2009;119(3):171–9.
Article
CAS
PubMed
Google Scholar
Rummel-Kluge C, Komossa K, Schwarz S, Hunger H, Schmid F, Lobos CA, et al. Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis. Schizophr Res. 2010;123(2–3):225–33.
Article
PubMed
PubMed Central
Google Scholar
Fernández Guijarro S, Miguel García C, Pomarol-Clotet E, Egea López EN, Burjales Martí MD, Rigol Cuadra MA. Metabolic syndrome screening in people with severe mental illness: results from two spanish community mental health centers. J Am Psychiatr Nurses Assoc. 2020;26(2):162–71.
Article
PubMed
Google Scholar
de Caluwé L, van Buitenen N, Gelan PJ, Crunelle CL, Thomas R, Casseres S, et al. Prevalence of metabolic syndrome and its associated risk factors in an African-Caribbean population with severe mental illness. Psychiatry Res. 2019;281:112558.
Article
PubMed
Google Scholar
Wang WS, Wahlqvist ML, Hsu CC, Chang HY, Chang WC, Chen CC. Age- and gender-specific population attributable risks of metabolic disorders on all-cause and cardiovascular mortality in Taiwan. BMC Public Health. 2012;12:111.
Article
CAS
PubMed
PubMed Central
Google Scholar
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;25(17):2735–52.
Article
Google Scholar
Guarner-Lans V, Rubio-Ruiz ME, Pérez-Torres I, Baños de MacCarthy G. Relation of aging and sex hormones to metabolic syndrome and cardiovascular disease. Exp Gerontol. 2011;46(7):517–23.
Article
CAS
PubMed
Google Scholar
Mosepele M, Letsatsi V, Mokgatlhe L, Hudson FP, Gross R. Cholesterol screening and statin prescription is low among HIV-infected patients on protease-inhibitor regimens in Botswana. Open AIDS J. 2017;11:45–51.
Article
CAS
PubMed
PubMed Central
Google Scholar
Samson SL, Garber AJ. Metabolic syndrome. Endocrinol Metab Clin North Am. 2014;43(1):1–23.
Article
PubMed
Google Scholar
Cui T, Yan BH, Liu Z, Yang H, Gyan M, Ma YX. Neck circumference: A valuable anthropometric measurement to detect metabolic syndrome among different age groups in China. Diabetes Metab Res Rev. 2018;34(3):e2966.
Namazi N, Larijani B, Surkan PJ, Azadbakht L. The association of neck circumference with risk of metabolic syndrome and its components in adults: a systematic review and meta-analysis. Nutr Metab Cardiovasc Dis NMCD. 2018;28(7):657–74.
Article
CAS
PubMed
Google Scholar
Mendes CG, Barbalho SM, Tofano RJ, Lopes G, Quesada KR, Detregiachi CRP, et al. Is neck circumference as reliable as waist circumference for determining metabolic syndrome? Metab Syndr Relat Disord. 2021;19(1):32–8.
Article
CAS
PubMed
Google Scholar
Møller SP, Amare H, Christensen DL, Yilma D, Abdissa A, Friis H, et al. HIV and metabolic syndrome in an Ethiopian population. Ann Hum Biol. 2020;47(5):457–64.
Article
PubMed
Google Scholar
Tsima BM, Moedi P, Maunge J, Machangane K, Kgogwane M, Mudojwa T, et al. Feasibility of implementing a novel behavioural smoking cessation intervention amongst human immunodeficiency virus-infected smokers in a resource-limited setting: A single-arm pilot trial. South Afr J HIV Med. 2020;21(1):1075.
Article
PubMed
PubMed Central
Google Scholar
Joseph P, Leong D, McKee M, Anand SS, Schwalm JD, Teo K, et al. Reducing the global burden of cardiovascular disease, part 1: the epidemiology and risk factors. Circ Res. 2017;121(6):677–94.
Article
CAS
PubMed
Google Scholar
Sud D, Laughton E, McAskill R, Bradley E, Maidment I. The role of pharmacy in the management of cardiometabolic risk, metabolic syndrome and related diseases in severe mental illness: a mixed-methods systematic literature review. Syst Rev. 2021;31(1):92.
Article
Google Scholar
De Hert M, Dekker JM, Wood D, Kahl KG, Holt RIG, Möller HJ. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry J Assoc Eur Psychiatr. 2009;24(6):412–24.
Article
Google Scholar